Politics. Awaiting M&A; We work in Silos; Management wants to innovate, but doesn't lead change; Uncertainty looms.
Pros
Low overhead in MO together with reasonable wages promotes ability to save $$$ for retirement, college, etc. Management opportunities for experienced newcomers are very good in drug development due to expansion of branded pharmaceuticals pipeline. Some colleagues are capable, bright, and friendly. Nice campus. Most people leave by 5:00-5:30 PM.
Cons
Public announcements of intentions to sell off Pharmaceuticals, Generics, and API businesses (i.e. the Missouri site) since April of 2011 cause great uncertainty. Senior management's vision to expand branded pharmaceuticals is poorly executed- aversion to risk, short-sightedness in developing a deep pipeline, and lack of innovation in the approach leads to small, incremental improvements to existing generics. These products must then compete in mature marketplaces as branded drugs at a high cost.
